Eisai and Arena Pharmaceuticals have announced that the FDA has accepted for filing the New Drug Application for an extended...
Neos Therapeutics, Inc. announced that the FDA has approved Adzenys ER (amphetamine) Extended-Release Oral Suspension. Neos Therapeutics is the only...
Flexion Therapeutics, Inc.announced that the FDA approved Zilretta (triamcinolone acetonide extended-release injectable suspension), the first and only extended-release, intra-articular injection...
The FDA has approved MorphaBond (morphine sulfate extended-release) tablets, for oral use, from Inspirion Delivery Technologies. MorphaBond is an abuse-deterrent...